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Purpose/Objective: Image Guided Adaptive Radiation 
Therapy (IGART) uses the Deformable Image Registration 
(DIR) between Computed Tomography (CT) and Cone-Beam 
CT (CBCT) images to calculate the delivered dose to the 
patient during treatment. Using this method we carried out a 
retrospective study of prostate cancer patients in order to 
study the weekly variations of delivered dose and evaluate 
the full treatment projecting on CT the delivered dose 
previously calculated on CBCT images. 
Materials and Methods: Five patients with prostate cancer 
were selected for a retrospective IGART study. VMAT 
treatments were planned on CT simulation images with 
RayStation 4.0 Treatment Planning System (TPS). For every 
patient, three of the five weekly CBCT studies they had were 
retrieved. For each CBCT, a Rigid Registration (RR) was 
made, setting CT and CBCT as primary and secondary images, 
respectively. Subsequently, a DIR by Hybrid Deformable 
Registration algorithm was run in order to map the CT's 
reference structures (ROIs) -external body contour, femoral 
heads, rectum, prostate and seminal vesicles (SV)- onto 
CBCT. A radiation oncologist reviewed the mapped structures 
and modified the non-matching structures by editing them. 
When some structures were modified was necessary to run a 
new DIR using these structures as control ROIs. Finally, VMAT 
plan was calculated on each CBCT and the resulting doses 
were projected to CT, achieving the total dose delivered on 
CT. The corresponding dose for the two non-retrieved weekly 
CBCT studies was estimated using the Raystation IGART 
module. 
Results: One patient was rejected because the field of view 
(FOV) cut the patient´s surface. The accuracy of DIR for 
moving structures such as rectum was lower than for fixed 
structures. Therefore, it was necessary to review the rectum 
contour and run again a new DIR using this structure as a 
control ROI. With respect to the external body contour, the 
weight loss suffered by the patient due to the diet during 
treatment introduced overdoses which were not computed in 
the initial dosimetry. One patient showed overdoses in 
rectum (5.6% and 4.7% for D25 and D20, respectively), 
whereas another patient showed a 4% overdose in D20. In 
both cases, the limits prescribed by radiation oncologist were 
exceeded. On the other hand, the variation of dose in fixed 
structures such as femoral heads was insignificant. Finally, 
one patient showed a 7.3% overdose in V98 for SV and 3.7% in 
V100 for the prostate. In general, a slight tendency to 
overdose was observed in patients who showed greater 
weight loss. 
 
 
 
Conclusions: Shape and volume of some organs, i.e. rectum, 
fluctuate during the treatment, resulting in a failure to meet 
the initial prescription doses. The implementation of a 
weekly IGART protocol study could detect such changes and 
allows an offline correction through the adaptive treatment. 
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Purpose/Objective: A detail analysis of 2437 IMPT fields that 
were clinically used for patient treatment between 2007 and 
2013 at PSI Gantry 1 was performed [1]. The aim of this study 
was to find out a possible correlation between the results of 
dosimetric verifications and specific field characteristics. 
Materials and Methods: Dosimetric verifications were 
performed for every IMPT field prior to patient treatment. 
For every field a steering file was generated containing all 
the treatment unit information necessary for treatment 
delivery: beam energy, beam angle, dose, size of air gap, 
nuclear interaction (NI) correction factor, number of range 
shifter plates, number of spots with their position and 
weight. This information was extracted and compared to the 
results of dosimetric verification of each field which was a 
measurement of two orthogonal profiles using an orthogonal 
ionization chamber array in a movable water column. 
Results: The data analysis has shown that the difference 
between measured and calculated dose depends critically on 
the number of spots and maximal range. Figure 1 displays the 
dose degradation as a function of the mean range and mean 
number of spots. An increase of the dose degradation was 
observed with smaller number of spots (i.e. smaller tumour) 
and smaller ranges (i.e. superficial tumours). Noteworthy, 
more than 94% of all verified fields were within defined 
clinical tolerances. Figure 1 does not reflect the frequency of 
each measured dose value. The results of the verification do 
not depend however on the prescribed dose, NI correction or 
